| 100965-3 |
Dengue virus Ab.IgG |
Imp |
Ser/Plas/Bld |
Pt |
Nom |
|
|
ACTIVE |
Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100965-3 |
|
|
|
|
Both |
|
|
|
0 |
DENV IgG SerPlBld-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Breakbone fever; Denv; Flavivirus; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100966-1 |
Oncofertility consultation note |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Oncofertility consultation note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
100966-1 |
|
|
|
|
Both |
|
|
|
0 |
Oncofertility consult note |
|
|
|
N |
|
Consult note; DOC.MISC; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MISC; notes; Oncofertility consult note; Point in time; Random; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100967-9 |
Fetal Heart Tracing |
Find |
^Fetus |
Pt |
Doc |
|
|
ACTIVE |
Fetal Document Fetal Heart Tracing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
100967-9 |
|
|
|
|
Both |
|
|
|
0 |
Fet Doc Fetal Heart Tracing |
|
|
|
N |
|
DOC.MISC; Document; Fetal; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100968-7 |
Bovine Tuberculosis Comparative Cervical Test panel |
- |
Skin |
Pt |
- |
|
|
ACTIVE |
Bovine tuberculosis comparative cervical test panel - Skin |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
100968-7 |
|
|
|
|
Order |
|
|
|
0 |
Bovine Tub comp cervical tst panel Skin |
|
|
|
N |
|
Beef; Bovine Tub comp cervical tst panel; Cerv; CHEMISTRY.CHALLENGE TESTING; Dermatologic; Epidermis; Integument; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Skn; TB |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100969-5 |
Pathology report.additional specified observation |
Find |
Specimen |
Pt |
Nar |
|
|
ACTIVE |
Pathology report additional specified observation in Specimen Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
100969-5 |
|
|
|
|
Both |
|
|
|
0 |
Path report.add spec obs Spec |
|
|
|
N |
|
Add; Finding; Findings; Narrative; Path; Path report.add spec obs; Pathology; Point in time; Random; Report; Spec |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10097-4 |
ST slope.lead I |
ElpotRat |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST slope in lead I |
|
MIN |
DefinitionDescription |
|
|
mV/s |
|
|
|
|
|
|
EKG.MEAS |
|
10097-4 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST Slope L-I |
|
|
|
Y |
|
Amperage; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Slope L-I; Voltage rate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV/s |
|
|
|
0 |
| 100970-3 |
Portable medical order completion information |
- |
^Patient |
- |
- |
POLST |
|
ACTIVE |
Portable medical order completion information |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100970-3 |
|
POLST |
|
|
Subset |
|
|
|
0 |
Portable med order completion info |
|
|
|
N |
|
CLIN; Portable med order completion info |
2.74 |
2.74 |
|
Organizer |
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100971-1 |
Clinical record panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Clinical record panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DOC |
|
100971-1 |
|
|
|
|
Order |
|
|
|
0 |
Clin rec panel |
|
|
|
N |
|
Clin rec panel; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random |
2.74 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100972-9 |
Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel |
- |
Nose |
Pt |
- |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
100972-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUABV+SARS-CoV2 RNA Pnl Nose NAA+nonprb |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2 RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; II; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Smell; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100973-7 |
Influenza virus A RNA |
PrThr |
Nose |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100973-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV RNA Nose Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Smell; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100974-5 |
Influenza virus B RNA |
PrThr |
Nose |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100974-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUBV RNA Nose Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Smell; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100975-2 |
Induced abortion method |
Type |
^Patient |
Pt |
Nom |
* |
|
ACTIVE |
Induced abortion method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
100975-2 |
|
* |
|
|
Both |
|
|
|
0 |
Induced abortion method |
|
|
|
N |
|
H+P; H+P.HX; Meth; Method of; Nominal; P prime; Point in time; Random; Typ |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100976-0 |
Eosinophil derived neurotoxin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
100976-0 |
|
|
|
|
Both |
|
|
|
0 |
EDN SerPl-mCnc |
|
|
|
N |
|
Chemistry; EDN; Eos; Eosin; Eosino; Eosinophils; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 100977-8 |
JC virus Ab Index |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
JC virus Ab Index in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
Index |
|
|
|
|
|
|
MICRO |
|
100977-8 |
|
IA |
|
|
Both |
|
|
|
0 |
JC virus Ab Index SerPl IA-aCnc |
|
|
|
N |
|
AI; Arbitrary concentration; EIA; ELFA; ELISA; Enzyme immunoassay; Human polyomavirus 2; IAA; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 100978-6 |
Thyroxine.free.gestational |
SCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
100978-6 |
|
IA |
|
|
Both |
|
|
|
0 |
Thyroxine.free.gestational SerPl IA-sCnc |
|
|
|
N |
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; FR; FreeT4; FT4; Gest; Gestation; IAA; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; MEIA; Non-protein bound; Pl; Plasma; Plsm; Point in time; Prenatal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; SUDS; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 |
2.75 |
2.74 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100979-4 |
Atopobium vaginae DNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100979-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
A vaginae DNA Ur Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; A vaginae; A vaginae DNA; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10098-2 |
ST slope.lead II |
ElpotRat |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST slope in lead II |
|
MIN |
DefinitionDescription |
|
|
mV/s |
|
|
|
|
|
|
EKG.MEAS |
|
10098-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST Slope L-II |
|
|
|
Y |
|
2; Amperage; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Slope L-II; Voltage rate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV/s |
|
|
|
0 |
| 100980-2 |
BK Virus DNA |
LnCnc |
CSF |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
log copies/mL |
|
|
|
|
|
|
MICRO |
|
100980-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
BKV DNA CSF NAA+probe-Log# |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Log_copies}/mL |
|
|
|
0 |
| 100981-0 |
Parvovirus B19 DNA |
LnCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
Log Copies/mL |
|
|
|
|
|
|
MICRO |
|
100981-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
B19V DNA Spec NAA+probe-Log# |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Log_copies}/mL |
|
|
|
0 |
| 100982-8 |
Varicella Zoster Virus DNA |
LnCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
Log Copies/mL |
|
|
|
|
|
|
MICRO |
|
100982-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
VZV DNA Spec NAA+probe-Log# |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Shingles; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load; VZ; VZV; Zoster |
2.75 |
2.74 |
|
|
|
|
|
|
|
{Log_copies}/mL |
|
|
|
0 |
| 100983-6 |
HIV reverse transcriptase failed codons |
Prid |
Isolate |
Pt |
Nom |
Genotyping |
|
ACTIVE |
HIV reverse transcriptase failed codons [Identifier] by Genotype method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100983-6 |
|
Genotyping |
|
|
Both |
|
|
|
0 |
HIV RT failed codons Islt Genotyp |
|
|
|
N |
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; HIV RT failed codons; Human immunodeficiency virus; Identity or presence; Islt; Isol; Nominal; Point in time; Random; REV; RT |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100984-4 |
HIV 1 group M RNA genotype |
Prid |
Isolate |
Pt |
Nom |
Genotyping |
|
ACTIVE |
HIV 1 group M RNA genotype [Identifier] by Genotype method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100984-4 |
|
Genotyping |
|
|
Both |
|
|
|
0 |
HIV 1 group M RNA Gentyp Islt Genotyp |
|
|
|
N |
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; Gentyp; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; Identity or presence; Islt; Isol; Nominal; Point in time; Random; Ribonucleic acid |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100985-1 |
HIV protease failed codons |
Prid |
Isolate |
Pt |
Nom |
Genotyping |
|
ACTIVE |
HIV protease failed codons [Identifier] by Genotype method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100985-1 |
|
Genotyping |
|
|
Both |
|
|
|
0 |
HIV protease failed codons Islt Genotyp |
|
|
|
N |
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; Human immunodeficiency virus; Identity or presence; Islt; Isol; Nominal; Point in time; PR; Random |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100986-9 |
HIV integrase failed codons |
Prid |
Isolate |
Pt |
Nom |
Genotyping |
|
ACTIVE |
HIV integrase failed codons [Identifier] by Genotype method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100986-9 |
|
Genotyping |
|
|
Both |
|
|
|
0 |
HIV integrase failed codons Islt Genotyp |
|
|
|
N |
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Genotype; Genotypic; Human immunodeficiency virus; Identity or presence; Islt; Isol; Nominal; Point in time; Random |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100987-7 |
Lymphocyte T-cell & B-cell & Natural killer subsets panel |
- |
CSF |
Pt |
- |
|
|
ACTIVE |
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
100987-7 |
|
|
|
|
Order |
|
|
|
0 |
Lymph Tcell+Bcell+NK subsets Pnl CSF |
|
|
|
N |
|
B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; CELL MARKERS; Cerebral spinal fluid; Cerebrospinal Fl; Lymph T-cell + B-cell + NK subset Pn; Lymph T-cell + B-cell + NK subsets; NK; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T cell; T prime; UCHL-1 |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
